$BCTX is expanding its cancer vaccine platform with Bria-MEL+, a personalized melanoma immunotherapy candidate. Simple saliva test helps match patients to premanufactured cell lines, eliminating individualized manufacturing.
News: https://bit.ly/4gNotWW
#CancerResearch